Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.57%267.16M | -11.88%262.71M | -4.19%296.83M | -38.63%1.17B | 9.26%300.49M | -19.67%263.04M | 298.11M | 309.82M | 31.26%1.91B | 327.45M |
| Cost of revenue | 2.66%216.57M | -10.74%220.05M | -4.91%227.57M | -30.41%953.17M | 22.51%256.37M | -11.95%210.96M | 246.52M | 239.31M | 65.65%1.37B | 239.6M |
| Gross profit | -2.85%50.59M | -17.30%42.66M | -1.76%69.26M | -59.35%220.85M | -32.90%44.12M | -40.72%52.07M | 51.59M | 70.51M | -13.84%543.31M | 87.85M |
| Operating expense | -25.73%279.42M | 57.91%376.22M | ||||||||
| Selling and administrative expenses | ---- | ---- | ---- | -32.61%25.87M | ---- | ---- | ---- | ---- | 128.88%38.39M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | -25.39%6.23M | ---- | ---- | ---- | ---- | 307.87%8.35M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -34.61%19.64M | ---- | ---- | ---- | ---- | 104.00%30.04M | ---- |
| Other operating expenses | ---- | ---- | ---- | -25.00%257.23M | ---- | ---- | ---- | ---- | 48.06%342.95M | ---- |
| Total other operating income | ---- | ---- | ---- | -28.11%3.68M | ---- | ---- | ---- | ---- | -49.55%5.12M | ---- |
| Operating profit | -2.85%50.59M | -17.30%42.66M | -1.76%69.26M | -135.05%-58.57M | -32.90%44.12M | -40.72%52.07M | 51.59M | 70.51M | -57.41%167.08M | 87.85M |
| Net non-operating interest income (expenses) | -133.87%-6.2M | 32.34%-8.81M | 60.34%-5.65M | 42.81%-24.07M | 37.88%-8.03M | 79.83%-2.65M | -13.02M | -14.24M | 2.93%-42.09M | -13.14M |
| Non-operating interest income | ---- | ---- | ---- | -59.69%13.71M | ---- | ---- | ---- | ---- | 407.58%34M | ---- |
| Non-operating interest expense | 133.87%6.2M | -32.34%8.81M | -60.34%5.65M | -50.53%37.93M | -37.88%8.03M | -79.83%2.65M | --13.02M | --14.24M | 53.05%76.68M | --13.14M |
| Total other finance cost | ---- | ---- | ---- | 73.47%-156K | ---- | ---- | ---- | ---- | -1,300.00%-588K | ---- |
| Net investment income | -297.93%-7.94M | 381.39%13.94M | 171.46%2.77M | -70.29%6.56M | -370.10%-15.09M | 133.90%4.01M | -4.96M | -3.88M | 144.40%22.08M | -11.84M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -167.49%-5.91M | -96.57%8.75M | ||||||||
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | ---- | ---- | ---- | 15.76%-759K | ---- | ---- | ---- | ---- | -90,000.00%-901K | ---- |
| Less:Write off | ---- | ---- | ---- | 184.91%6.67M | ---- | ---- | ---- | ---- | -182.77%-7.85M | ---- |
| Other non-operating income (expenses) | 22.41%-39.32M | 22.33%-38.82M | 17.89%-42.69M | 153.17%3.59M | -101.67%-88.76M | -16.14%-50.68M | -49.98M | -51.99M | 141,700.00%1.42M | -43.63M |
| Income before tax | -204.28%-2.87M | 154.92%8.98M | 5,753.58%23.71M | -149.86%-78.39M | -570.61%-67.76M | -85.67%2.76M | -16.36M | 405K | -74.35%157.24M | 19.23M |
| Income tax | -76.55%-13.51M | 94.74%-691K | 8,210.03%115.65M | -96.77%11.25M | 224.47%27.19M | -166.36%-7.65M | -13.14M | -1.43M | 469.13%348.03M | 11.53M |
| Net income | 2.18%10.63M | 401.09%9.67M | -5,121.41%-91.94M | 53.02%-89.64M | -362.00%-94.95M | 35.07%10.41M | -3.21M | 1.83M | -126.97%-190.79M | 7.71M |
| Net income continuous operations | 2.18%10.63M | 401.09%9.67M | -5,121.41%-91.94M | 53.02%-89.64M | -362.00%-94.95M | 35.07%10.41M | ---3.21M | --1.83M | -126.97%-190.79M | --7.71M |
| Noncontrolling interests | -208.26%-1.39M | -25.13%-10.27M | -2.19%-12.91M | 44.55%-39.28M | -61.95%-18.24M | 122.94%1.28M | -8.21M | -12.63M | -144.92%-70.84M | -5.6M |
| Net income attributable to the company | 31.80%12.02M | 299.46%19.94M | -646.54%-79.04M | 58.01%-50.36M | -261.47%-76.71M | -31.42%9.12M | 4.99M | 14.46M | -121.82%-119.95M | 13.3M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 31.80%12.02M | 299.46%19.94M | -646.54%-79.04M | 58.01%-50.36M | -261.47%-76.71M | -31.42%9.12M | 4.99M | 14.46M | -121.82%-119.95M | 13.3M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 34.62%0.0035 | 280.00%0.0057 | -595.65%-0.0228 | 60.26%-0.0151 | -246.36%-0.0221 | -38.10%0.0026 | 0.0015 | 0.0046 | -121.49%-0.038 | 0.0042 |
| Diluted earnings per share | 34.62%0.0035 | 280.00%0.0057 | -595.65%-0.0228 | 60.26%-0.0151 | -246.36%-0.0221 | -38.10%0.0026 | 0.0015 | 0.0046 | -121.51%-0.038 | 0.0042 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.